Nephrotic syndrome: Difference between revisions
From IDWiki
Content deleted Content added
Imported from text file |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
== |
== Background == |
||
* Clinical syndrome characterized by massive proteinuria, which results in hypoalbuminema, hyperlipidemia, and edema |
|||
* Syndrome characterized by: |
|||
* Can be primary (idiopathic) or secondary |
|||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
=== Etiologies === |
|||
| ⚫ | |||
==== Common ==== |
|||
| ⚫ | |||
| ⚫ | |||
* [[Systemic lupus erythematosus]] (14%) |
|||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
==== Exhaustive ==== |
|||
* Non-proliferative glomerulonephritis |
* Non-proliferative glomerulonephritis |
||
** Minimal change disease |
** [[Minimal change disease]] |
||
*** Primary |
*** Primary |
||
*** Drugs |
*** Drugs |
||
**** NSAIDs and COX-2 inhibitors |
**** [[NSAIDs]] and COX-2 inhibitors |
||
**** Ampicillin, rifampicin, cephalosporins |
**** [[Ampicillin]], [[rifampicin]], [[cephalosporins]] |
||
**** Lithium |
**** [[Lithium]] |
||
**** D-penicillamine and tiopronin |
**** [[D-penicillamine]] and [[tiopronin]] |
||
**** Pamidronate |
**** [[Pamidronate]] |
||
**** Sulfasalazine and 5- |
**** Sulfasalazine and [[5-ASA]] |
||
**** Interferon-gamma |
**** [[Interferon-gamma]] |
||
*** Neosplasms |
*** Neosplasms |
||
**** Hodgkin lymphoma |
**** [[Hodgkin lymphoma]] |
||
**** Non-Hodgkin lymphoma |
**** [[Non-Hodgkin lymphoma]] |
||
**** Leukemia |
**** [[Leukemia]] |
||
*** Lupus nephritis V (membranous nephritis) |
*** [[Lupus nephritis]] V (membranous nephritis) |
||
** Focal segmental glomerulosclerosis |
** Focal segmental glomerulosclerosis |
||
*** Primary |
*** Primary |
||
*** Severe obesity and other hyperfiltration syndromes |
*** Severe [[obesity]] and other hyperfiltration syndromes |
||
*** Infections |
*** Infections: [[HIV]], [[parvovirus B19]], [[CMV]], [[EBV]] |
||
**** HIV |
|||
**** Parvovirus B19 |
|||
**** CMV |
|||
**** EBV |
|||
*** Drugs |
*** Drugs |
||
**** Heroin |
**** Heroin |
||
**** Interferons |
**** Interferons |
||
**** Pamidronate |
**** [[Pamidronate]] |
||
**** Anabolic steroids |
**** Anabolic steroids |
||
**** mTOR |
**** mTOR inhibitors |
||
**** Calcineurin |
**** Calcineurin inhibitors |
||
**** Anthracyclines |
**** Anthracyclines |
||
**** Lithium |
**** Lithium |
||
*** Other |
*** Other |
||
**** Sickle cell anemia |
**** [[Sickle cell anemia]] |
||
**** Thrombotic microangiopathy |
**** [[Thrombotic microangiopathy]] |
||
**** Genetic disorders |
**** Genetic disorders |
||
** Membranous nephropathy |
** Membranous nephropathy |
||
*** Primary |
*** Primary |
||
*** [[Systemic lupus erythematosus]] |
|||
*** Lupus |
|||
*** Drugs: [[gold]], [[penicillamine]], [[NSAIDs]] |
|||
*** Drugs |
|||
*** Infections: [[hepatitis B]] and [[hepatitis C]], [[malaria]], [[syphilis]] |
|||
**** Gold |
|||
**** Penicillamine |
|||
**** NSAIDs |
|||
*** Infections |
|||
**** Hepatitis B and C |
|||
**** Malaria |
|||
**** Syphilis |
|||
*** Neoplasms |
*** Neoplasms |
||
**** Non-Hodgkin lymphoma |
**** [[Non-Hodgkin lymphoma]] |
||
**** Solid cancers |
**** Solid cancers |
||
*** IgG4 disease |
*** [[IgG4 disease]] |
||
=== Most common causes === |
|||
| ⚫ | |||
| ⚫ | |||
* Lupus (14 percent) |
|||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
* If < 20 years old |
* If < 20 years old |
||
** Minimal change (70%) |
** Minimal change (70%) |
||
| Line 82: | Line 68: | ||
** Minimal change (20%) |
** Minimal change (20%) |
||
** Focal segmental glomerulosclerosis (10%) |
** Focal segmental glomerulosclerosis (10%) |
||
== Clinical Manifestations == |
|||
* Edema progressing to anasarca |
|||
* May have frothy urine |
|||
* Fatigue, anorexia |
|||
* May develop DVT/PE |
|||
* Found to have proteinuria, hyperlipidemia, and hypoalbuminemia on investigations |
|||
** Often also have hypocalcemia |
|||
== Investigations == |
|||
* For diagnosis: urine protein, lipid panel, albumin levels |
|||
* For secondary causes: send HBV, HCV, HIV, syphilis, HbA1c, ANA, SPEP/UPEP, cryoglobulins, RF, CH50, C3, C4 |
|||
* Often needs kidney biopsy |
|||
* May need imaging for DVT or PE |
|||
| ⚫ | |||
* Definition of the syndrome: |
|||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
* Diagnosis of the underlying cause often requires renal biopsy |
|||
== Management == |
== Management == |
||
Latest revision as of 16:07, 2 March 2026
Background
- Clinical syndrome characterized by massive proteinuria, which results in hypoalbuminema, hyperlipidemia, and edema
- Can be primary (idiopathic) or secondary
Etiologies
Common
- Membranous nephropathy (24%)
- Minimal change disease (16%)
- Systemic lupus erythematosus (14%)
- FSGS (12%): more common in black patients
- Amyloidosis (6 to 17%): more common in older patients
- Membranoproliferative glomerulonephritis (7%)
- IgA nephropathy (6%)
Exhaustive
- Non-proliferative glomerulonephritis
- Minimal change disease
- Primary
- Drugs
- NSAIDs and COX-2 inhibitors
- Ampicillin, rifampicin, cephalosporins
- Lithium
- D-penicillamine and tiopronin
- Pamidronate
- Sulfasalazine and 5-ASA
- Interferon-gamma
- Neosplasms
- Lupus nephritis V (membranous nephritis)
- Focal segmental glomerulosclerosis
- Primary
- Severe obesity and other hyperfiltration syndromes
- Infections: HIV, parvovirus B19, CMV, EBV
- Drugs
- Heroin
- Interferons
- Pamidronate
- Anabolic steroids
- mTOR inhibitors
- Calcineurin inhibitors
- Anthracyclines
- Lithium
- Other
- Sickle cell anemia
- Thrombotic microangiopathy
- Genetic disorders
- Membranous nephropathy
- Primary
- Systemic lupus erythematosus
- Drugs: gold, penicillamine, NSAIDs
- Infections: hepatitis B and hepatitis C, malaria, syphilis
- Neoplasms
- Non-Hodgkin lymphoma
- Solid cancers
- IgG4 disease
- Minimal change disease
Epidemiology
- If < 20 years old
- Minimal change (70%)
- Membranous (20%)
- Focal segmental glomerulosclerosis (10%)
- If > 20 years old
- Membranous (70%)
- Minimal change (20%)
- Focal segmental glomerulosclerosis (10%)
Clinical Manifestations
- Edema progressing to anasarca
- May have frothy urine
- Fatigue, anorexia
- May develop DVT/PE
- Found to have proteinuria, hyperlipidemia, and hypoalbuminemia on investigations
- Often also have hypocalcemia
Investigations
- For diagnosis: urine protein, lipid panel, albumin levels
- For secondary causes: send HBV, HCV, HIV, syphilis, HbA1c, ANA, SPEP/UPEP, cryoglobulins, RF, CH50, C3, C4
- Often needs kidney biopsy
- May need imaging for DVT or PE
Diagnosis
- Definition of the syndrome:
- Significant proteinuria > 3g/day
- Hyperlipidemia/lipiduria
- Anasarca
- Hypoalbuminemia <35g/L
- Diagnosis of the underlying cause often requires renal biopsy
Management
- If < 20 years old
- Treat empirically with steroids, as the majority are primary minimal change disease
- If > 20 years old
- Needs kidney biopsy to direct treatment